Moderna, Inc. (MRNA) Income Annual - Discounting Cash Flows
MRNA
Moderna, Inc.
MRNA (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
Report Filing 2026-02-20 2026-02-20 2025-02-21 2024-02-23 2023-02-24 2022-02-25 2021-02-26 2020-02-27 2019-03-13 2017-12-31 2016-12-31
Revenue 1,943 1,944 3,199 6,848 18,875 17,736 803.4 60.21 135.1 205.8 108.4
Cost of Revenue 1,669 868 1,464 4,693 5,416 2,617 39.18 31.02 24.86 20.54 15.11
Gross Profit 274 1,076 1,735 2,155 13,459 15,119 764.2 29.19 -319 185.3 93.28
Operating Expenses 3,348 4,150 5,680 6,394 4,039 1,823 1,527 574.9 149.9 454.6 317.1
Research & Development 3,132 3,132 4,543 4,845 3,295 1,991 1,370 496.3 454.1 410.5 274.7
Selling, General and Administrative 1,018 1,018 1,174 1,549 1,132 567 188.3 109.6 94.25 64.72 57.45
Other Operating Expenses -802 0 -37 0 -388 -735 -31.25 -31.02 -398.5 -20.54 -15.11
Operating Income -3,074 -3,074 -3,945 -4,239 9,420 13,296 -763.1 -545.7 -468.9 -269.4 -223.8
Net Non-Operating Interest 312 314 401 383 171 0 14.83 31.92 23.93 15.1 11.31
Interest Income 314 314 425 421 200 18 24.71 38.53 27.02 15.23 11.31
Interest Expense 2 0 24 38 29 18 9.89 6.61 3.1 0.132 0
Equity & Other Income/(Expense) -6 -8 -63 -86 -16 -11 3.8 -0.914 4.93 -1.74 -2.71
Income Before Tax -2,768 -2,768 -3,607 -3,942 9,575 13,285 -744.5 -514.7 -440 -256 -215.2
Income Tax Expense 54 54 -46 772 1,213 1,083 2.55 -0.695 0.326 -0.08 1.04
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0 0 -55.6 0 0
Net Income -2,822 -2,822 -3,561 -4,714 8,362 12,202 -747.1 -514 -384.7 -255.9 -216.2
Depreciation and Amortization 215 215 189 621 348 232 31.25 31.02 24.86 20.54 15.11
EBITDA -2,859 -2,859 -3,756 -3,618 9,768 13,528 -731.9 -514.7 -444 -248.8 -208.7
Earnings Per Share (EPS) -7.27 -7.26 -9.27 -12.34 21.26 30.31 -1.96 -1.55 -1.17 -0.72 -3.79
Diluted Earnings Per Share -7.27 -7.26 -9.27 -12.34 20.1 28.29 -1.96 -1.55 -1.17 -0.72 -3.79
Weighted Average Shares Outstanding 392 389 384 382 394 403 381.3 330.8 328.8 376 64.09
Diluted Weighted Average Shares Outstanding 392 389 384 382 416 431 381.3 330.8 328.8 376 64.09
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program